GlassScriptPhysician profile
Heather D Pugmire
NPI 1225292220
$2,873.24
in general payments reported to CMS, 2019-2025
21 companies · $27.23 in 2025
The $27.23 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,156 · 2020: $168 · 2021: $54.17 · 2022: $191 · 2023: $121 · 2024: $154 · 2025: $27.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $302.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $2,090.84 | 2019-2022 | |
| Abbvie INC. | $114.69 | 2019-2022 | |
| Astellas Pharma US INC | $107.66 | 2021-2024 | Veozah |
| Ethicon US, LLC | $73.12 | 2022-2024 | Surgiflo Hemostatic Matrix, Ethicon |
| Coloplast Corp | $68.69 | 2023-2024 | Altis |
| Hologic Sales and Service, LLC | $68.69 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.37 | 2019-2022 | |
| Exeltis, USA INC. | $47.15 | 2022 | |
| Myriad Women'S Health, INC. | $32.63 | 2023 | |
| Amag Pharmaceuticals, INC. | $30.98 | 2019 | |
| Therapeuticsmd, INC. | $30.59 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $30.05 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $27.23 | 2025 | Myfembree |
| Covidien LP | $26.25 | 2019 | |
| Shield Therapeutics INC | $21.76 | 2023 | Accrufer |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $16.60 | 2023 | |
| Allergan, INC. | $14.09 | 2020 | |
| Agile Therapeutics, INC. | $12.50 | 2022 | |
| Avanos Medical | $11.35 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Pugmire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.